Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sanil Bhatia

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
Cell Death & Disease|May 17, 2025
Deep transfer learning approach for automated cell death classification reveals novel ferroptosis-inducing agents in subsets of B-ALLPaweł Stachura, Zhe Lu, Raphael M Kronberg, et al.
Biochemical Pharmacology|September 17, 2023
High-throughput screening as a drug repurposing strategy for poor outcome subgroups of pediatric B-cell precursor Acute Lymphoblastic LeukemiaAthanasios Oikonomou, Luigia Valsecchi, Manuel Quadri, et al.
Cell Communication and Signaling : CCS|November 13, 2024
Targeting mitochondrial metabolism by the mitotoxin bromoxib in leukemia and lymphoma cellsLaura Schmitt, Karina S Krings, Andre Wolsing, et al.
Cell Death & Disease|November 8, 2022
The mycotoxin viriditoxin induces leukemia- and lymphoma-specific apoptosis by targeting mitochondrial metabolismFabian Stuhldreier, Laura Schmitt, Thomas Lenz, et al.
Cell Death & Disease|December 23, 2025
Small-molecule inhibitor of C‑terminal HSP90 dimerization modulates autophagy and functions synergistically with mTOR inhibition to kill cisplatin-resistant cancer cellsCéline David, Yadong Sun, Vitalij Woloschin, et al.
Blood Advances|July 15, 2024
A brain organoid/ALL coculture model reveals the AP-1 pathway as critically associated with CNS involvement of BCP-ALLPhilip Gebing, Stefanos Loizou, Sebastian Hänsch, et al.
Cell Death & Disease|March 7, 2026
Epigenetic remodeling via HDAC6 inhibition amplifies anti-tumoral immune responses in myeloid leukemia cellsJulian Schliehe-Diecks, Jia-Wey Tu, Pawel Stachura, et al.
Cell Death Discovery|March 9, 2024
Novel meriolin derivatives activate the mitochondrial apoptosis pathway in the presence of antiapoptotic Bcl-2Laura Schmitt, Ilka Lechtenberg, Daniel Drießen, et al.
Frontiers in Immunology|April 25, 2022
The Mycotoxin Beauvericin Exhibits Immunostimulatory Effects on Dendritic Cells <i>via</i> Activating the TLR4 Signaling PathwayXiaoli Yang, Shafaqat Ali, Manman Zhao, et al.
Cell Death & Disease|December 6, 2023
Co-targeting HSP90 alpha and CDK7 overcomes resistance against HSP90 inhibitors in BCR-ABL1+ leukemia cellsMelina Vogt, Niklas Dienstbier, Julian Schliehe-Diecks, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Cell Death & Disease|May 17, 2025
Deep transfer learning approach for automated cell death classification reveals novel ferroptosis-inducing agents in subsets of B-ALLPaweł Stachura, Zhe Lu, Raphael M Kronberg, et al.
Biochemical Pharmacology|September 17, 2023
High-throughput screening as a drug repurposing strategy for poor outcome subgroups of pediatric B-cell precursor Acute Lymphoblastic LeukemiaAthanasios Oikonomou, Luigia Valsecchi, Manuel Quadri, et al.
Cell Communication and Signaling : CCS|November 13, 2024
Targeting mitochondrial metabolism by the mitotoxin bromoxib in leukemia and lymphoma cellsLaura Schmitt, Karina S Krings, Andre Wolsing, et al.
Cell Death & Disease|November 8, 2022
The mycotoxin viriditoxin induces leukemia- and lymphoma-specific apoptosis by targeting mitochondrial metabolismFabian Stuhldreier, Laura Schmitt, Thomas Lenz, et al.
Cell Death & Disease|December 23, 2025
Small-molecule inhibitor of C‑terminal HSP90 dimerization modulates autophagy and functions synergistically with mTOR inhibition to kill cisplatin-resistant cancer cellsCéline David, Yadong Sun, Vitalij Woloschin, et al.
Blood Advances|July 15, 2024
A brain organoid/ALL coculture model reveals the AP-1 pathway as critically associated with CNS involvement of BCP-ALLPhilip Gebing, Stefanos Loizou, Sebastian Hänsch, et al.
Cell Death & Disease|March 7, 2026
Epigenetic remodeling via HDAC6 inhibition amplifies anti-tumoral immune responses in myeloid leukemia cellsJulian Schliehe-Diecks, Jia-Wey Tu, Pawel Stachura, et al.
Cell Death Discovery|March 9, 2024
Novel meriolin derivatives activate the mitochondrial apoptosis pathway in the presence of antiapoptotic Bcl-2Laura Schmitt, Ilka Lechtenberg, Daniel Drießen, et al.
Frontiers in Immunology|April 25, 2022
The Mycotoxin Beauvericin Exhibits Immunostimulatory Effects on Dendritic Cells <i>via</i> Activating the TLR4 Signaling PathwayXiaoli Yang, Shafaqat Ali, Manman Zhao, et al.
Cell Death & Disease|December 6, 2023
Co-targeting HSP90 alpha and CDK7 overcomes resistance against HSP90 inhibitors in BCR-ABL1+ leukemia cellsMelina Vogt, Niklas Dienstbier, Julian Schliehe-Diecks, et al.
Pageof 6